AIP
ATOS icon

Ameritas Investment Partners’s Atossa Therapeutics ATOS Stock Holding History

Ameritas Investment Partners’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-826
Closed -$8.34K – 3211
2025
Q1 		$8.34K Hold
826
– – ﹤0.01% 2873
2024
Q4 		$11.7K Hold
826
– – ﹤0.01% 2861
2024
Q3 		$18.8K Hold
826
– – ﹤0.01% 2689
2024
Q2 		$14.7K Buy
+826
New +$18.3K ﹤0.01% 2751
2022
Q2 		– Sell
-612
Closed -$11K – 3074
2022
Q1 		$11K Hold
612
– – ﹤0.01% 2750
2021
Q4 		$15K Hold
612
– – ﹤0.01% 2756
2021
Q3 		$30K Hold
612
– – ﹤0.01% 2465
2021
Q2 		$58K Buy
+612
New +$32.4K ﹤0.01% 2090

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return